DelveInsight launched a new report on Complex Regional Pain Syndrome (CRPS) Market Insights, Epidemiology and Market Forecast 2030.
DelveInsight’s ‘Complex Regional Pain Syndrome (CRPS) Market 2030’ report delivers an in-depth understanding of the CRPS, historical and forecasted epidemiology as well as the CRPS market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.
Complex regional pain syndrome (CRPS) is one of the most challenging chronic pain condition that is characterized by progressively worsening spontaneous regional pain without dermatomal distribution. The pain experienced is out of proportion in time and severity to the inciting event and accompanied by symptoms that vary in severity including skin changes, autonomic dysfunction, abnormal sensory and motor changes, and trophic changes.
CRPS may develop after major trauma, surgery, or minor injury, and progresses with a variable course that ranges from self-limiting, mild symptomatology to chronic disease. In many cases, disease progression is debilitating and severely limits patients’ quality of life, creating a tremendous burden on patients and their families. Over time, CRPS has been defined and redefined. CRPS develops after an inciting noxious stimulus to an affected limb. There is little agreement with regards to the etiology, symptoms, clinical presentation, diagnosis, or treatment of CRPS.
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-market
Complex Regional Pain Syndrome Epidemiology Insights:
1. In the United States, the total number of prevalent cases of CRPS was 219,317 cases in the year 2017 which are expected to grow during the study period, i.e., 2017–2030.
2. In the 7MM, the total gender-specific diagnosed prevalent cases of CRPS were 47,699 for males and 102,987 for females in the year 2017.
Complex Regional Pain Syndrome (CRPS) Therapy Assessment
1. Soticlestat (TAK-935/OV935): Ovid Therapeutics/Takeda
2. BHV-5000: AstraZeneca/Biohaven Pharmaceutical
Click here and get access to free sample pages of the report.
Table of contents
1 Key Insight 2 Executive Summary of Complex Regional Pain Syndrome (CRPS) 3 Complex Regional Pain Syndrome (CRPS) Market Overview at a Glance 4 Disease Background and Overview: Complex Regional Pain Syndrome (CRPS) 5 Case Reports 6 Complex Regional Pain Syndrome (CRPS) Epidemiology and Patient Population 7 United States Epidemiology 8 EU5 Epidemiology 9 Japan Epidemiology 10 Current Complex Regional Pain Syndrome (CRPS) Treatment and Medical Practices 11 Unmet needs 12 Complex Regional Pain Syndrome (CRPS) Marketed Drugs 13 Complex Regional Pain Syndrome (CRPS) Emerging Drugs 14 Complex Regional Pain Syndrome (CRPS) 7MM Market Analysis 15 United States 16 EU-5 countries: Market Outlook 17 Japan Market Outlook 18 Complex Regional Pain Syndrome (CRPS) Market Drivers 19 Complex Regional Pain Syndrome (CRPS) Market Barriers 20 SWOT Analysis 21 Reimbursement and market access 22 Appendix 23 DelveInsight Capabilities 24 Disclaimer 25 About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/